2000
DOI: 10.1054/clnu.2000.0142
|View full text |Cite
|
Sign up to set email alerts
|

Cost containment through L-alanyl-L-glutamine supplemented total parenteral nutrition after major abdominal surgery: a prospective randomized double-blind controlled study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0
6

Year Published

2005
2005
2017
2017

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 70 publications
(45 citation statements)
references
References 45 publications
1
38
0
6
Order By: Relevance
“…Several controlled trials in specific subgroups of postsurgical and other types of patients have shown beneficial clinical or metabolic effects when GLN is added to PN. 25,[31][32][33][34][35]39,41,42 These studies have incorporated L-GLN doses in PN ranging from 0.29 to 0.57 g/kg/d, 25,[31][32][33][34][35]39 and alanyl-GLN dipeptide doses similar to the dose used in the current trial (0.40-0.50 g/kg/d or equivalent to 0.26-0.33 g of L-GLN/kg/d). However, several trials also show no benefits, possibly attributable to differences in study patient clinical characteristics and degree of GLN depletion within and between studies, as well as the dose of parenteral GLN used.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several controlled trials in specific subgroups of postsurgical and other types of patients have shown beneficial clinical or metabolic effects when GLN is added to PN. 25,[31][32][33][34][35]39,41,42 These studies have incorporated L-GLN doses in PN ranging from 0.29 to 0.57 g/kg/d, 25,[31][32][33][34][35]39 and alanyl-GLN dipeptide doses similar to the dose used in the current trial (0.40-0.50 g/kg/d or equivalent to 0.26-0.33 g of L-GLN/kg/d). However, several trials also show no benefits, possibly attributable to differences in study patient clinical characteristics and degree of GLN depletion within and between studies, as well as the dose of parenteral GLN used.…”
Section: Discussionmentioning
confidence: 99%
“…This dose of alanyl-GLN dipeptide was based on results of previous safety and efficacy studies of GLN-supplemented PN. [31][32][33][34][35] This dose of GLN dipeptide provides 23 g of L-GLN daily for a 70-kg subject (two-thirds of alanyl-GLN is the GLN moiety). The study amino acid solutions were designed to be essentially isonitrogenous; the STD-PN solution provides 2.35 g of nitrogen and the GLN-PN provides 2.45 g of nitrogen per 100 mL of amino acid solution.…”
Section: Nutrition Supportmentioning
confidence: 99%
“…Esses dados são compatíveis com os resultados encontrados em estudos randômicos e controlados, realizados em adultos internados em UTI, queimados e em pós--operatório. Nestes estudos, a suplementação da glutamina não promoveu redução da mortalidade em pacientes pós-cirúrgicos, mostrando apenas tendência à redução desta variável em pacientes criticamente enfermos 8,25,[29][30][31][32] .…”
Section: Exclusão Durante Estudounclassified
“…Apesar da presente revisão não evidenciar vantagens do uso da glutamina em reduzir o tempo de internação 10,11,13 , sendo detectada apenas uma tendência a essa redução no estudo de Lacey et al 12 , a literatura evidencia reduções significantes no tempo de hospitalização, nos estudos com adultos pós-cirúrgicos, com doenças hematológicas e com adultos criticamente enfermos 8,22,27,28,31,32 .…”
Section: Exclusão Durante Estudounclassified
“…To improve mental function, to control blood sugar levels and to maintain muscle mass, it is also utilized by the body. L-alanyl-L-glutamine (Ala-Gln) dipeptide which is an substantial biological active molecule has various, effective, and important biological activities such as; decreasing effect of infection, dehiscence, abcess, mortality in critically ill patients and length of stay after operation [1], preventive effect of the inhibition of migration, apoptosis [2], improving effect of replenishment of depleted glutathione stores, nitrogen balance, immune defenses, growth performance of piglets [3][4][5][6][7], increasing effect of protein synthesis, ameliorates immune function [3][4][5], protective effect of intestinal barrier permeability [3][4][5], and also shows effective properties on control of diabetes in liver transplanted patients, survival and activities of digestive enzyme, enzymatic antioxidative status [8][9]. It is also used as an immunomodulator in addition to knowing that chemotherapy side effects are diminised.…”
Section: Introductionmentioning
confidence: 99%